Pfizer
Duke Researchers Use Veracyte Data to ID Prostate Cancer Subgroups for Added Post-Surgery Treatment
Premium
The recent JCO Precision Oncology study could bolster the research use case for Veracyte's Decipher GRID database in better defining prostate cancer subgroups.
Foundation Medicine Blood Test Gets FDA Approval as CDx for Pfizer's Braftovi in Colorectal Cancer
The FDA has approved the FoundationOne Liquid CDx assay to identify patients with BRAF V600E alterations eligible for treatment with Braftovi.
Top Five Articles on 360Dx Last Week: Siemens Healthineers Layoffs and Atellica Focus; and More
Last week, readers were most interested in a story about changes at Siemens Healthineers as it plans to shut down some of its legacy instruments.
Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.
Top Five Articles on 360Dx Last Week: Curative Spinoff Dx Firm; Pfizer Buys Lucira Health; and More
Last week, readers were most interested in a story about Sensible Diagnostics, which will commercialize a 10-minute point-of-care PCR testing platform.
Jan 20, 2022
Jan 18, 2022
Sema4 to Acquire GeneDx for $623M
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Feb 24, 2020
Apr 30, 2019
Exact Sciences Q1 Revenues Up 79 Percent
Oct 30, 2018
Exact Sciences Q3 Revenues Up 63 Percent
Oct 12, 2018
AmoyDx Lung Cancer CDx Approved in South Korea
Aug 22, 2018